Lorena P. Suarez‐Kelly

619 total citations
20 papers, 366 citations indexed

About

Lorena P. Suarez‐Kelly is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lorena P. Suarez‐Kelly has authored 20 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Lorena P. Suarez‐Kelly's work include Sarcoma Diagnosis and Treatment (4 papers), Vascular Tumors and Angiosarcomas (3 papers) and CAR-T cell therapy research (3 papers). Lorena P. Suarez‐Kelly is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Vascular Tumors and Angiosarcomas (3 papers) and CAR-T cell therapy research (3 papers). Lorena P. Suarez‐Kelly collaborates with scholars based in United States, Italy and Saudi Arabia. Lorena P. Suarez‐Kelly's co-authors include William E. Carson, Lianbo Yu, Amanda R. Campbell, Susheela Tridandapani, Jonathan P. Butchar, Megan Duggan, John H. Howard, Brooke Benner, Emily Smith and Robert A. Baiocchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Frontiers in Immunology.

In The Last Decade

Lorena P. Suarez‐Kelly

20 papers receiving 365 citations

Peers

Countries citing papers authored by Lorena P. Suarez‐Kelly

Since Specialization

Citations

This map shows the geographic impact of Lorena P. Suarez‐Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena P. Suarez‐Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena P. Suarez‐Kelly more than expected).

Fields of papers citing papers by Lorena P. Suarez‐Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena P. Suarez‐Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena P. Suarez‐Kelly. The network helps show where Lorena P. Suarez‐Kelly may publish in the future.

Co-authorship network of co-authors of Lorena P. Suarez‐Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena P. Suarez‐Kelly. A scholar is included among the top collaborators of Lorena P. Suarez‐Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena P. Suarez‐Kelly. Lorena P. Suarez‐Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma 2021 ·Frontiers in Immunology ·Steven Sun, Brooke Benner, (unknown), (unknown), (unknown), (unknown), (unknown), Megan Duggan, Andrew Stiff, (unknown), Lorena P. Suarez‐Kelly, Amanda R. Campbell, Lianbo Yu, Robert Wesolowski, H. J. Howard, Hiral Shah, Kari Kendra, William E. Carson	24
2	Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation 2021 ·ACS Applied Nano Materials ·Lorena P. Suarez‐Kelly, Steven Sun, (unknown), (unknown), (unknown), Megan Duggan, (unknown), (unknown), (unknown), (unknown), Lianbo Yu, Vedat Yildiz, Jonathan P. Butchar, Susheela Tridandapani, Arfaan Rampersaud, William E. Carson	20
3	Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi‐institutional analysis of the US Sarcoma Collaborative 2020 ·Journal of Surgical Oncology ·Jason T. Wiseman, Cecilia G. Ethun, Jordan M. Cloyd, (unknown), Lorena P. Suarez‐Kelly, Thuy B. Tran, George A. Poultsides, Harveshp Mogal, Callisia N. Clarke, (unknown), Kevin K. Roggin, Konstantinos Chouliaras, Konstantinos I. Votanopoulos, Bradley A. Krasnick, Ryan C. Fields, (unknown), Sean M. Ronnekleiv‐Kelly, John H. Howard, Kenneth Cardona, Valerie P. Grignol	19
4	736 MicroRNA expression patterns in melanomas originating from gynecologic sites 2020 ·SHILAP Revista de lepidopterología ·(unknown), Lorena P. Suarez‐Kelly, (unknown), (unknown), (unknown), Paolo Fadda, Lianbo Yu, Sarah B. Peters, Alejandro A. Gru, William E. Carson	1
5	Abstract 3696: Determination of the expression patterns and functional implications of microRNAs in ulcerated cutaneous melanoma 2020 ·Cancer Research ·(unknown), (unknown), Lorena P. Suarez‐Kelly, (unknown), (unknown), Paolo Fadda, Lianbo Yu, John H. Howard, Alejandro A. Gru, William E. Carson	2
6	Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial 2019 ·BMC Cancer ·Lorena P. Suarez‐Kelly, (unknown), (unknown), Stephen P. Povoski, William E. Carson, (unknown)	11
7	A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma 2019 ·Cancer Immunology Immunotherapy ·Lorena P. Suarez‐Kelly, (unknown), Thomas Olencki, Sara E. Martin del Campo, (unknown), Taylor Brooks, Volodymyr Karpa, Joseph Markowitz, (unknown), Susan M. Geyer, Kari Kendra, William E. Carson	8
8	Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas 2019 ·Journal of Surgical Research ·Malcolm H. Squires, Cecilia G. Ethun, Lorena P. Suarez‐Kelly, Peter Y. Yu, Tasha M. Hughes, (unknown), Thuy B. Tran, George A. Poultsides, (unknown), T. Clark Gamblin, Jennifer F. Tseng, Kevin K. Roggin, Konstantinos Chouliaras, Konstantinos I. Votanopoulos, Bradley A. Krasnick, Ryan C. Fields, Raphael E. Pollock, Valerie P. Grignol, Kenneth Cardona, John H. Howard	3
9	Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro 2019 ·Journal for ImmunoTherapy of Cancer ·Brooke Benner, (unknown), Lorena P. Suarez‐Kelly, Megan Duggan, Amanda R. Campbell, Emily Smith, (unknown), (unknown), Jonathan P. Butchar, Susheela Tridandapani, John H. Howard, Robert A. Baiocchi, Thomas A. Mace, William E. Carson	113
10	Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature 2019 ·Hereditary Cancer in Clinical Practice ·Lorena P. Suarez‐Kelly, Lianbo Yu, David Kline, Eric B. Schneider, Doreen M. Agnese, William E. Carson	36
11	Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments 2019 ·Expert Opinion on Pharmacotherapy ·Lorena P. Suarez‐Kelly, Giacomo Giulio Baldi, Alessandro Gronchi	16
12	Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma 2018 ·Journal of Surgical Research ·Peter Y. Yu, Eliza W. Beal, Tasha M. Hughes, Lorena P. Suarez‐Kelly, (unknown), Cecilia G. Ethun, Thuy B. Tran, George A. Poultsides, John A. Charlson, T. Clark Gamblin, Jennifer F. Tseng, Kevin K. Roggin, Konstantinos Chouliaras, Konstantinos I. Votanopoulos, Bradley A. Krasnick, Ryan C. Fields, Raphael E. Pollock, Valerie P. Grignol, Kenneth Cardona, John H. Howard	2
13	Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity 2018 ·Molecular Case Studies ·Lorena P. Suarez‐Kelly, Keiko Akagi, Julie W. Reeser, Eric Samorodnitsky, (unknown), Amy Smith, Sameek Roychowdhury, David E. Symer, William E. Carson	6
14	MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions 2017 ·Cancer Immunology Research ·Amanda R. Campbell, Megan Duggan, Lorena P. Suarez‐Kelly, (unknown), (unknown), Elizabeth L. McMichael, Prashant Trikha, Robin Parihar, (unknown), (unknown), Bryant C. Yung, Robert J. Lee, David H. Raulet, Susheela Tridandapani, Veronika Groh, Lianbo Yu, Vedat Yildiz, John C. Byrd, Michael A. Caligiuri, William E. Carson	15
15	Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation 2017 ·Behavioural Brain Research ·Leah M. Pyter, Lorena P. Suarez‐Kelly, William E. Carson, (unknown), (unknown), (unknown)	26
16	Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Lorena P. Suarez‐Kelly, Amanda R. Campbell, (unknown), Ambika Bumb, Min S. Wang, Jonathan P. Butchar, Susheela Tridandapani, Lianbo Yu, Arfaan Rampersaud, William E. Carson	31
17	Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors 2016 ·Journal of Surgical Research ·Nicholas Latchana, Kelly Regan, John H. Howard, Jennifer H. Aldrink, Mark Ranalli, Sara Peters, Xiaoli Zhang, Alejandro A. Gru, Philip Payne, Lorena P. Suarez‐Kelly, William E. Carson	15
18	Fluorescent nanodiamonds and their use in biomedical research 2016 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Lorena P. Suarez‐Kelly, (unknown), (unknown), Amanda R. Campbell, Zhiwei Hu, Masfer Alkahtani, (unknown), P. R. Hemmer, William E. Carson, Arfaan Rampersaud	4
19	The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma 2016 ·Oncotarget ·Lorena P. Suarez‐Kelly, (unknown), Megan Duggan, Andrew Stiff, (unknown), Joseph Markowitz, (unknown), Vedat Yildiz, Lianbo Yu, Alena Cristina Jaime‐Ramirez, Volodymyr Karpa, Xiaoli Zhang, William E. Carson	11
20	Dead or alive? New confirmatory test using quantitative analysis of computed tomographic angiography 2015 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Lorena P. Suarez‐Kelly, (unknown), (unknown), (unknown), William Bromberg, (unknown), Jay U. Howington, Frank E. Davis	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact